IV Flush Syringe Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The IV Flush Syringe market is segmented by Product (Saline IV Flush Syringe and Heparin IV Flush Syringe), End-User (Hospital & Clinics, Ambulatory Surgical centers, and Others), and Geography (North America, Europe, Asia-Pacific, Rest of the World). The report offers the value (in USD million) for the above segments.

Market Snapshot

123
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The IV flush syringe market is expected to register a CAGR of 6.0% over the forecast period, 2022-2027.

The advent of COVID-19 resulted in burdening of healthcare infrastructure worldwide as most elective healthcare treatments were postponed. Moreover, the demand for these IV flush syringes such as saline IV flush syringes and heparin IV flush syringes witnessed a decline due to a decline in hospital admission of non-covid patients. Also, the number of surgeries has been reduced due to a lack of healthcare professionals, and supply chain & logistic disruption has reduced the demand for the product in the market.  Many of the patients suffering from chronic diseases were treated remotely from home to prevent the risk of disease transmission and unburden healthcare facilities. Thus, the market would undergo a negative impact due to a lack of demand for IV flush syringes.

Furthermore, increasing chronic disorders are expected to propel the demand for IV flush syringes. In the year 2020, as per the data provided by the healthcare cost & utilization project, cardiac diseases, arthritis, COPD, and diabetes are factors supporting in-patient hospital stays in the United States. For instance, In 2020, as per the Centers for Disease Control and Prevention estimates suggested a higher diagnosed prevalence of COPD in the United States with 17,455,605 diagnosed cases in 2020, which might increase in 2030, thus the increasing cases of COPD in the respective country would raise the rate of hospitalizations which would generate the need for IV flush syringes in the treatment process. Also, In the year 2019 as per a national health council study, the number is projected to grow to an estimated 157 million, with 81 million having multiple chronic conditions in the United States. Thus, the increasing number of chronic diseases is generating the need for the usage of IV flush syringes market.

Increasing awareness about the benefits of using an IV Flush Syringe also drives the growth of this market. Health care providers use IV flushes to clear out intravenous lines that deliver medicine directly into the veins of a patient. Flushes are administered before and after starting IV medication drips or fluids in patients. This ensures the lines stay clean and prevents blockages. When used correctly, IV flush syringes could make life much easier for health care providers and patients. The devices increase workflow efficiency in care settings and usually decrease the risk of infection. They also decrease the risk of needlestick injuries among health care professionals. For instance, BD PosiFlush SP Pre-Filled Saline Syringe assist in improving clinician efficiency and workflow by eliminating steps and time involved in the manual preparation of saline syringes. Thus, the advantages associated with IV Flush syringes are rising demand for the product which is boosting the market growth.

However, fluctuations in the prices of the final product are quietly hampering the demand of the market. Lack of sufficient knowledge in handling the syringes owing to few training programs is restraining the demand of the market. Replacement of other types of syringes instead of IV flush syringes is restricting the growth of the market.

Scope of the Report

As per the scope of the report, IV flush syringes are medical devices utilized to clear intravenous lines. When utilized correctly, saline flushes are generally safe and well tolerated by patients, but complications could occur. Although rare, IV flush syringes could introduce air embolisms into a vein, that could lead to heart attacks, strokes, and respiratory failure. Contaminated syringes have been linked to serious bacterial infections in patients. In rare cases, a serious allergic reaction may occur. The IV Flush Syringe market is segmented by Product (Saline IV Flush Syringe and Heparin IV Flush Syringe), End-User (Hospital & Clinics, Ambulatory Surgical centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product
Saline IV Flush Syringe
Heparin IV Flush Syringe
By End-User
Hospital & Clinics
Ambulatory Surgical centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World

Report scope can be customized per your requirements. Click here.

Key Market Trends

Hospitals & clinics Segment is Expected to Witness Growth Over the Forecast Period

The hospitals & clinics segment holds a significant share in the market for IV Flush Syringe due to the increasing chronic & acute diseases, and stringent government regulations to minimize errors in the treatment. Furthermore, rising awareness among the end-users to increase patient compliance is anticipated to fuel the growth of the IV flush syringes market.

While the increasing number of hospital admissions and advanced healthcare infrastructure is further propelling the growth of the market. There had been a rapid surge in the total number of hospitalizations worldwide due to various chronic conditions, which in turn increases the demand for IV flush syringes. For example, as per AHA Hospital Statistics, 2022 edition, total Admissions in all United States Hospitals were estimated at 33,356,853. Since IV flush syringes play an important role during medication administration and tests, resulting in rising demand for the product in hospitals. Also, As per the American Hospital Association (AHA) survey, the total number of hospital admissions in the United States reached 36,241,815 in 2019 and 36,30,0000 in 2018. Thus, the number of hospital admissions is rising continuously owing to the increase in chronic disorders that is generating the need for IV flush syringes market in treatment processes.

Moreover, As per the article published by Jyoti Sharma in January 2022 on 'Flushing of catheters' stated that In advanced clinical practice, up to 4/5th of the hospitalized patients usually requires intravenous therapy at some point in their treatment processes during their hospital stay. Flushes are administered before and after starting IV medication drips or fluids in patients to ensure the lines stay clean and prevent blockages. This is likely to fuel the hospital segment growth in the forthcoming years.

Thus, all these factors are responsible for segment growth that is fueling the IV flush syringes market.

123

North America is Expected to Dominate the IV Flush Syringe Market

In 2020, North America holds a significant share in the market owing to the acceptance of novel technologies, increasing cases of chronic diseases, rising number of surgical procedures performed and increasing research and development activities that have contributed to the growth of the market in this region.

The U.S. held the major market share of the North American IV flush syringe market owing to the rising incidences of chronic disorders, and the rising number of hospitalization that require IV flush syringes which is responsible for the growth of the market. For instance, As per the World Health Organisation, In 2021, around 15 percent of adults in the United States reported having at least two chronic medical conditions, while only around 11 percent of older millennials reported the same. As IV flush syringes play an important role during medication administration and tests which is responsible for the rising demand for the product that would propel the market growth.

The increasing cases of chronic disorders give rise to the number of surgeries that would generate the requirement for IV flush syringe market in the treatment. For instance, In 2020, as per the National Health Statistics Reports around 129 million surgical procedures are performed every year in the United States. Thus, the increasing number of surgeries is boosting the growth of the market. Thus, all these factors are expected to boost the growth of the market.

123

Competitive Landscape

The key companies operating in the IV flush syringe market are BD (Becton, Dickinson, and Company), B. Braun Melsungen AG, Cardinal Health, Nipro Corporation, Medline Industries, LP, Medefil, Inc., Polymedicure, Aquabiliti and SteriCare Solutions. The major companies operating in the IV Flush Syringe Market invest heavily in manufacturing expansion to increase manufacturing facility efficiency and fuel market position. For instance, In July 2019, Medefil, Inc. undertook manufacturing expansion to enhance manufacturing facility efficiency. This strategy could enhance the production of flushes and injectable products. This strategy may enable the company to enhance product quality and fuel production and achieve a remarkable market position. Additionally, companies adopt research and development, partnerships, mergers, novel product launches, and acquisition strategies to fuel boost their market position.

Recent Development

  • In July 2021, American weekly magazine newsweek recognized Medline Industries, LP by mentioning its two product names in its list ‘Best infection prevention products 2021. These two products are ‘Prefilled SwabFlush syringe with SwabCap and ‘ReadyPrep CHG’.
  • In April 2021, Nipro Corporation introduced CURACASE, a Hypodermic needle used for Hard-Plastic Unit Packaging. The needles could strengthen the supply and manufacturing of injection systems.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise In Awareness And Favorable Guidelines For Single Use Syringes

      2. 4.2.2 Rising Burden Of Chronic Diseases And Infectious Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Guidelines coupled with Increasing number of recalls for IV Flush Syringes

      2. 4.3.2 Lack of Sufficient Knowledge in Handling the Syringes due to Less Training Programs

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product

      1. 5.1.1 Saline IV Flush Syringe

      2. 5.1.2 Heparin IV Flush Syringe

    2. 5.2 By End-User

      1. 5.2.1 Hospital & Clinics

      2. 5.2.2 Ambulatory Surgical centers

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Rest of the World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 BD (Becton, Dickinson and Company)

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Cardinal Health

      4. 6.1.4 Nipro Corporation

      5. 6.1.5 Medline Industries, LP

      6. 6.1.6 Medefil, Inc.

      7. 6.1.7 Polymedicure

      8. 6.1.8 Aquabiliti

      9. 6.1.9 SteriCare Solutions

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global IV Flush Syringe Market market is studied from 2019 - 2027.

The Global IV Flush Syringe Market is growing at a CAGR of 6% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

BD (Becton, Dickinson and Company) , B. Braun Melsungen AG , Cardinal Health , Nipro Corporation , Medline Industries, LP are the major companies operating in Global IV Flush Syringe Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!